Endometriosis
Estrogens
Leuprolide
Prostatic Neoplasms
Testosterone

Leuprolide

Leuprolide acetate, a gonadotropin-releasing hormone agonist, is a cornerstone therapy in hormone-dependent conditions, including advanced prostate cancer, endometriosis, uterine leiomyomata, and central precocious puberty. It acts through pituitary desensitization to suppress gonadal steroid production, resulting in reversible reductions in estrogen and testosterone levels. This activity reviews leuprolide s mechanism of action, indications, formulation-specific dosing strategies, safety profile, and key monitoring considerations, including metabolic, cardiovascular, and bone health effects. Participants will gain competence in selecting appropriate formulations, optimizing dosing regimens, recognizing adverse effects, and applying contraindications in clinical practice. Emphasis is placed on evidence-based management and the importance of interprofessional collaboration among physicians, pharmacists, nurses, and other healthcare professionals to optimize patient outcomes. By participating in this activity, healthcare professionals enhance their competence in evidence-based, collaborative management of patients receiving leuprolide across diverse clinical settings.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.